New facility, vendor-inclusive digital stack

The challenge:

A diversified Fortune 500 biopharma company built a new viral-vector gene-therapy facility but was constrained by siloed instruments, point-to-point integrations, and inconsistent data formats that slowed production and quality work. 

Stellix’s role:

We led a front-end engineering design (FEED) study to define what it would take to implement a Unified Namespace (UNS) data architecture—replacing brittle point-to-point links with a governed, vendor-inclusive data backbone that connected equipment, systems, and analytics in real time. 

The outcome:

The facility moved from ad-hoc integrations to a UNS-ready architecture that support higher-throughput, viral-vector production, simpler analytics, and a scalable foundation for future MES, AI, and tech transfer use cases—without having to re-platform core systems as the site evolves.